Jackson: Lower Respiratory Tract Infections Flashcards
Lower Respiratory Tract Infections
Children vs adults:
• Age is a key determinant for pneumonia:
o Children: viruses are primary causes; bacteria cause secondary infections
o Adult: depends on a variety of risk factors
Adult pneumonia may be CA or HA/Nosocomial
CA Risks:
HA Risks:
o CA Risks: alcohol abuse, occupational exposure, underlying condition
o HA Risks: immunocompromise and mechanical ventilation
Atypical pneumonias are caused by:
also defined as:
• Atypical pneumonias are caused by a pathogen other than S.pneumo: also defined as primary pneumonia that did NOT involve an initiating viral infection
Streptococcus pneumoniae (Pneumococcus) Virulence Factors (Relevant to Lower Respiratory Tract Infections): (3)
o Polysccharide capsule (90 serotypes)
o Pneumolysin
o Cell Wall TA and Peptidoglycan
Streptococcus pneumoniae (Pneumococcus) Polysccharide capsule (90 serotypes): Prevents: (2) Facilitates: What confers host immunity?
o Polysccharide capsule (90 serotypes): primary virulence factor
• Prevents complement deposition (C3b)
• Prevents phagocytosis by alveolar macrophages
• Facilitates evasion of lung surfactant
• Abs to capsule confer host immunity
Streptococcus pneumoniae (Pneumococcus) Pneumolysin: Damages membranes (related to?) \_\_\_\_\_\_\_is cell membrane receptor Acts on several cell types:
o Pneumolysin: sulfhydryl activated cytolysin (hemolysin)
• Damages membranes (related to SLO); subunits oligomerize in cell membrane to form a pore
• Cholesterol is cell membrane receptor
• Acts on several cell types (pulmonary epithelium, PMNs and monocytes)
Streptococcus pneumoniae (Pneumococcus)
Pneumolysin
Role in Pathognesis
Evasion of:
Clearance from:
May permit:
Cell-bound form activates:
- Evasion of the immune response and clearance from nasopharynx
- May permit spread to bloodstream from alveoli (bacteremia)
- Cell-bound form activates complement, contributes to inflammation
Streptococcus pneumoniae (Pneumococcus) Cell Wall TA and Peptidoglycan
Gram (+) Shock:
Activates:
Production of:
Gram (+) Shock: strong inflammatory response (similar to LPS in G negative); inflammation elicits fever and lung damage (bloody sputum)
- Activate alternate complement pathway
- Production of IL-1 and TNF alpha
Streptococcus pneumoniae (Pneumococcus)
Exclusively a human pathogen:
Transmission:
Exclusively a human pathogen: many asymptomatic carriers (transient carriage also possible)
Transmission: person to person (droplet spread)
Streptococcus pneumoniae (Pneumococcus)
Recurrent pneumococcal pneumonia:
Note:
Recurrent pneumococcal pneumonia: is a presenting manifestation of AIDS
Note: Most common cause of acute bacterial pneumonia in any age group
Streptococcus pneumoniae (Pneumococcus)
Establishment of Organism in Lower Respiratory Tract:
Common causes of compromised cough:
Aspiration of pneumococci from middle respiratory tract
Compromised cough reflex permits entry into lower respiratory tract
- Common Causes: stroke, alcoholism, drugs, anesthesia, viral infection
• Alveolar Abs usually clear pneumococci from lower respiratory tract
Streptococcus pneumoniae (Pneumococcus) Acute Pneumonia
Cough:
Inflammatory Response:
o Acute Pneumonia: infection of lung parenchyma
• Cough: with productive sputum (purulent material from alveoli)
• Inflammatory Response:
➢ Complement components increase vascular permeability (fluid accumulates)
➢ Disrupted gas exchange (suffocation)
Streptococcus pneumoniae (Pneumococcus) Secondary Complications
Bacteremia:
Acute Purulent Meningitis:
Pneumococci adhere to:
Pneumococci breach:
Bacteremia: due to inflammatory response and damage to endothelial cells
Acute Purulent Meningitis: bacteremia may lead to meningitis
- Pneumococci adhere to vascular endothelium in CNS and cause cell death
- Pneumococci breach BBB/BCB to enter CSF
.
Streptococcus pneumoniae (Pneumococcus)
Sputum Gram Stain:
Major Problem:
Sputum Gram Stain: important diagnostic tool, but issues
Major Problem: contamination with flora from oropharynx
➢ Sputum is MONOMICROBIC and contains PMNs
➢ Contaminating saliva is POLYMICROBIC and has squamous epithelial cells
Streptococcus pneumoniae (Pneumococcus)
G+/-?
Hemolysis:
Lancefield Grouping:
- G(+) lancet shaped diplococcic
- Alpha-hemolytic
- No Lancefield grouping
Streptococcus pneumoniae (Pneumococcus)
Biochemical Tests: (4)
- Capsular serotyping
- Quelling reaction (anti-capsule Abs)
- Optochin (P disk) sensitive
- Bile soluble (distinguish from viridians strep
Streptococcus pneumoniae (Pneumococcus)
Blood Culture:
- Detects bacteremia and confirms sputum sample
* Latex agglutination used to detect circulating pneumococcal Abs
Streptococcus pneumoniae (Pneumococcus)
Radiology:
o Radiology: shows bronchopneumonia that can consolidate to lobar pneumonia
Haemophilus influenzae Virulence Factors (Relevant to Lower Respiratory Tract Infections):
Polysaccharide capsule
• Anti-phagocytic
• Subject to Ag variation
• Hib most virulent (capsular serotype B)
Haemophilus influenzae
Normal Flora:
Transmission:
Peak Age Group:
o Normal Flora: commonly in upper respiratory tract
• Humans can be carriers of both encapsulated and non-encapsulated (non-typable) strains
o Transmission: person to person (droplet)
o Peak Age Group: 2-5 years old
Haemophilus influenzae
Pneumonia: can be caused by both encapsulated and non-encapsulated strains
Encapsulated:
Hib pneumonia:
Encapsulated: similar disease to pneumococcal pneumonia
- Hib pneumonia: increased virulence with a higher incidence of positive blood cultures (less common than non-typable because lower colonization rates)
Haemophilus influenzae
Pneumonia: can be caused by both encapsulated and non-encapsulated strains
Non-Encapsulated:
• Non-Encapsulated: less virulent
Haemophilus influenzae
Predisposing Factors of Nontypable Pneumonia: (3)
o Chronic bronchitis
o Emphysema
o Obstructive pulmonary disease
Haemophilus influenzae
Acute Epiglotittitis:
Acute Epiglotittitis: can also be caused by H.influenzae
Haemophilus influenzae
Sample Collection:
Cultures:
Sputum and blood cultures (positive in 10-15% of patients; higher with Hib pneumonia)
Cultures:
• G(-) coccobacilli
• Fastidious (requires X and V blood factors for growth)
Legionella pneumophilia
Etiology:
Parasite of freshwater and soil protozoa: Acanthomoeba, Naeglaria
Found in reservoirs for ameba/bacteria (cooling towers, AC systems, plumbing, hospital respiratory equipment); routine disinfection of cooling systems used as prevention
Existence inside ameba provides survival advantage
➢ More resistant to disinfectants
➢ Can survive over winter inside cyst of ameba
➢ May be capable of living outside of ameba in biofilms
Legionella pneumophilia
Transmission:
Transmission: inhalation (but NO person-to-person spread)
Legionella pneumophilia
Acute Pneumonia
virulence in humans:
Contributors to pathogenesis:
- Generally low virulence in humans: most people have Abs because of it ubiquity in nature
- Contributors to pathogenesis: nosocomial infections, immunocompromise, smoking, excessive alcohol use, old age
Legionella pneumophilia
Legionnaire’s Disease:
Legionnaire’s Disease: severe pneumonia with a 2-10 day incubation period (high mortality rate, especially in immunocompromise)
Legionella pneumophilia
Pontiac Fever:
Pontiac Fever: nonpneumonic (no pneumonia) febrile illness with a 1-2 day incubation period (self-limiting); may be immune response to inhalation of dead/low virulence strains
Legionella pneumophilia
Disseminated Disease:
Disseminated Disease: very rare; usually presents with pneumonia after a long incubation period (days-weeks)
Legionella pneumophilia
Disease Process
Inhaled organism has tropism for:
Has a surface protein that binds:
Inhaled organism has tropism for lung alveoli and bronchioles (forms microabsecesses)
Has a surface protein that binds C3 (enhances its own phagocytosis)
➢ “Coiling” phagocytosis
➢ Uptake may also occur without opsonization (bacteria-induced phagocytosis)
Legionella pneumophilia
Disease Process
Survives in monocytes/macrophages as:
Once in the cell, expresses 30 new proteins that:
Multiplication of Legionella is normally inhibited in:
• Survives in monocytes/macrophages as intracellular parasite
• Once in the cell, expresses 30 new proteins that:
➢ Prevent phagolysosome fusion and acidification of the endocytotic vesicle
➢ Induce accumulation of ribosomes and mitochondria around phagosome
➢ Facilitate scavenging of iron from transferrin
• Multiplication of Legionella is normally inhibited in an activated macrophage
Legionella pneumophilia
Clinical ID
Urine EIA test for:
Normal staining and culture techniques:
Gram Stain:
Growth media:
Urine EIA test for soluble Ag
Normal staining and culture techniques not useful:
Does not Gram stain well:
➢ May be visualized with simple stains devoid of decolorization or silver impregnation
➢ Appears thin, pleomorphic G(-) rod with filamentous forms also seen
Growth media:
➢ Requires amino acids L-cysteine, and ferric ions
➢ Also needs to be on buffered medium (pH restrictions)
➢ Slow growth (2-5 days)
Legionella pneumophilia
Clinical ID
Microscopic exam of tissue required:
Legionella should be suspected in cases of:
Organism is rarely found in:
Identification based on:
Microscopic exam of tissue required: since Gram stain not useful
Legionella should be suspected in cases of severe progressive pneumonia with no known etiologic agent
Organism is rarely found in sputum
➢ Need to collect lung aspirate, transtracheal aspirate, or lung biopsy
Identification based on antigenic structure and DNA homology tests
➢ Indirect immunofluorescence of serum (rise in Ab titer to Legionella)
➢ Difficult to assess due to high exposure rates in population
Legionella pneumophilia
Clinical ID
PCR: Serological Diagnosis (Summary Chart):
o PCR: used by reference lab for identification (most human infections caused by Philadelphia strain)
o Serological Diagnosis (Summary Chart): immunofluorescence
Acinetobacter spp.
Etiology
Environment:
Antibiotic resistant:
Frequent cause of:
Etiology
o Environment: lives in soil, water and on the skin of healthy people (especially healthcare workers); can survive on dry surfaces for up to 20 days
o Antibiotic resistant: innately resistant to man classes of antibiotics
o Frequent cause of nosocomial infections
Acinetobacter spp.
Pathogenesis:
Clinical ID:
- Pathogenesis: causes pneumonia and serious blood/wound infections in immunocompromised patients
- Clinical ID: G(-) coccobacillus (resembles Haemophilus)
Mycoplasma pneumoniae Virulence Factors (Relevant to Lower Respiratory Tract Infections)
Adhesin:
Hydrogen peroxide:
Adhesin: binds sialic acid containing glycolupids or glycoproteins on bronchial epithelial cells
Hydrogen peroxide: damages tissue
Mycoplasma pneumoniae Virulence Factors (Relevant to Lower Respiratory Tract Infections)
Superoxide:
Autoantibodies may be generated during infection:
Superoxide: damages tissue
Autoantibodies may be generated during infection: homology between host cell and mycoplasma membrane glycolipids; reactive to lymphocytes, smooth muscle, brain, lung tissue
Mycoplasma pneumoniae
Common age group:
Transmission:
o Common age group: teenagers
o Transmission: droplet spread (very low infectious dose); common in closed communities
• Organism shed both before and long after onset of symptoms
Mycoplasma pneumoniae
Pathogenesis
Walking Pneumonia:
Disease Process:
o Walking Pneumonia: less severe than other bacterial pneumonias
o Disease Process:
• Colonization of bronchial epithelium interferes with ciliary action
• Inflammation and exudate are the primary contributors to pathogenesis
Mycoplasma pneumoniae
Pathogenesis
Second Infection Site:
Second Infection Site: non-purulent otitis media
Mycoplasma pneumoniae
Sequelae
Immunopathology due to:
Possible complications: (3)
Immunopathology due to cross-reactive Abs
Possible complications:
➢ Hemolytic anemia
➢ Aseptic meningitis
➢ Pancreatitis
Mycoplasma pneumoniae
Culture
sputum:
culture:
Gram stain:
microscopically:
- No organism in sputum
- Organism grows too slow to culture (require cholesterol for growth)
- No Gram stain (no cell wall)
- Difficult to detect microscopically
Mycoplasma pneumoniae
Structure:
Serodiagnosis:
Structure:
• Lack cell wall (no Gram stain or treatment with B-lactams); bound by triple membrane containing sterols
Serodiagnosis: can be used to detect circulating Ags or complement-fixing Ab
• Ab to M.pneumoniae is diagnostic (disease has a long IP so patient presents with high titers)
Mycoplasma pneumoniae
DNA hybdrization or PCR:
Serological Diagnosis:
o DNA hybdrization or PCR: also being developed for detection
o Serological Diagnosis (Summary Chart): complement fixation or IgM titers (ELISA)
Chlamydia pneumoniae
Virulence Factors (Relevant to Lower Respiratory Tract Infections)
Life Cycle: (2)
Life Cycle:
• Elementary Body: infectious stage that carries adhesin for receptor binding (attaches and induces endocytosis into columnar epithelial cells)
• Reticulate Body: replicates once in cell; metabolically active (uses host ATP)
➢ Eventually reorganize and release infectious EB from the cell
Chlamydia pneumoniae
Hosts:
It causes:
Humans are only host: ~50% of adults seropositive, but reinfection still occurs
Causes:
• Pharyngitis
• Bronchitis
• Atypical Pneumonia (Walking Pneumonia): in school children and young adults
Chlamydia pneumoniae
Pathogenesis:
Clinical picture resembles M.pneumoniae
Chlamydia pneumoniae
Clinical ID
Morphology/Growth:
Detection:
Serological Diagnosis (Summary Chart):
Morphology/Growth:
• G(-) outer membrane, but no cell wall (cannot Gram stain or treat with B-lactams)
• Coccobacillus
• Inclusions are glycogen (-)
Detection:
• Direct immunofluorescent staining of outer membrane proteins
• DNA or RNA detection using probes and PCR
• Inclusions do not contain glycogen
Serological Diagnosis (Summary Chart): immunofluorescence or ELISA